Abstract:Food protein-derived peptides have been recognised as an important category of functional food materials, which exert various bioactivities and possible health-promoting impacts in human beyond their traditional nutritional values (Hern andez-Ledesma & Hsieh, 2017; Aguilar et al., 2019). Bioactive peptides could be produced by food processing processes such as fermentation, etc., from longer polypeptides or proteins. A growing body of scientific evidence has demonstrated that peptides bearing characteristic sequences can prevent various lifestyle-related diseases such as diabetic, hypertension and atherosclerosis. In addition to bioactivities, current peptide researches focus on physiological stability in the gastrointestinal tract as well as intestinal absorption to understand the bioaccessibility and bioavailability of bioactive peptides (Matsui, 2018). This special issue summarises current understandings on bioaccessibility and bioavailability of food protein-derived bioactive peptides, which also include a review on clinical aspects of bioactive peptides, as well as future challenges and ongoing research needs in the field of peptide science. Written by world renowned leading scientists, it is hoped that the knowledge and insights gained from this special issue will lead to further development in the rapidly growing field of bioactive peptides from food proteins. Epidemiological studies have revealed that consumption of milk and fermented dairy products is inversely associated with elevated blood pressure and with many of the risk factors of the metabolic syndrome and combats against hypertension and vascular dysfunction. An overview of the potential blood pressure lowering components present in dairy products with a special focus on casein-derived tripeptides was described. Dairy proteinderived bioactive peptides (DBPs) have potential benefits for human health. However, their transport mechanisms and bioavailability from intestinal lumen to bloodstream are not well understood. Understanding of their transport mechanisms across the intestinal membrane (peptide transporter 1, paracellular route, transcytosis and passive transcellular diffusion) and the bioavailability of DBPs in animal and human studies were highlighted. Current research on in vitro and in vivo absorption of these compounds and factors that play a key role in this process provides better understanding of the in vitro and in vivo bioavailability and bioaccessibility of peptides. Peptides display diverse structural features because of their varied amino acid compositions. The structural diversity often imparts them complex physiological functions or possible health-beneficial effects. Some small peptides (di-/tripeptides) exert preventive effects against conditions such as hypertension, hypercholesterolaemia and atherosclerosis. Despite their health benefits, a limited understanding of peptide absorption may hinder their extensive application. Therefore, in vitro and in vivo findings on the intestinal absorption of small peptides and potential factors affecting their absorption were emphasised. Bioactive peptides can be protected from the gastrointestinal environment by microencapsulation. Microcapsules obtained by spray drying using maltodextrin/gun arabic in optimal formula preserved the a-glucosidase, a-amylase and dipeptidyl peptidase-IV inhibitory activity of P. lunatus peptides after in vitro gastrointestinal digestion. Lupine (Lupinus angustifolius L.) protein (in wholemeal and protein isolates) was biodegraded using Pediococcus acidilactici in submerged and solid-state fermentation conditions. Biodegradation improved the antioxidant properties, modulated the antimicrobial properties and led to higher in vitro and in vivo digestibility and functionality of the lupine in treated rats. Diabetes mellitus is a complex disorder caused by insufficient insulin production or insulin resistance. It was to update the state-of-the-art regarding the origin, structural characteristics, action and potential mechanisms of bioactive peptides on the key enzymes and proteins, i.e., a-amylase, a-glucosidase. Epidemiological studies have shown that soy consumption is associated with lower incidence of various diseases, including cancer. Over the past decades, soy proteins and derived peptides have been considered as potential preventive agent against the initiation, promotion and progression of cancer. Specifically emphasising This Editorial should have been published in Special Issue 54:6 (‘Bioaccessibility and bio-availability of food derived bioactive peptides’) but, due to a production error, was published in issue 54:7 instead. The publisher apologizes for this error and the inconvenience caused. International Journal of Food Science and Technology 2019, 54, 2319–2320

Bioactive peptides derived from traditional Chinese medicine and traditional Chinese food: A review

A Review: Interactions Between Protein from Blue Foods and Functional Components in Delivery Systems: Function Exertion and Transmembrane Transport by in Vitro Digestion/cells Model

Bioactive Peptides of Plant Origin: Distribution, Functionality, and Evidence of Benefits in Food and Health

Production and Functionality of Food-derived bioactive peptides: A review.

The Alteration of Gut Microbiota by Bioactive Peptides: a Review

A comprehensive review of specific activity and intrinsic connections of food-derived bioactive peptides for human health

A Comprehensive Review of Specific Activity and Intrinsic Connections of Food‐derived Bioactive Peptides for Human Health

The Research Progress of Bioactive Peptides Derived from Traditional Natural Products in China

Advancement and Prospects of Bioinformatics Analysis for Studying Bioactive Peptides from Food-Derived Protein: Sequence, Structure, and Functions

The current research status and strategies employed to modify food-derived bioactive peptides

Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential

Food Protein-Derived Bioactive Peptides for the Management of Nutrition Related Chronic Diseases

Interplay of Food-Derived Bioactive Peptides with Gut Microbiota: Implications for Health and Disease Management

Molecular Characteristics and Structure-Activity Relationships of Food-Derived Bioactive Peptides

A Review of Bioactive Peptides: Chemical Modification, Structural Characterization and Therapeutic Applications

Current understanding of bioaccessibility and bioavailability of food‐derived bioactive peptides

Therapeutic peptides in the treatment of digestive inflammation: Current advances and future prospects

Multiple roles of food-derived bioactive peptides in the management of T2DM and commercial solutions: A review

Recent Advances in Exploring and Exploiting Soybean Functional Peptides-a Review.

Bioactive Peptides With Antidiabetic Properties: A Review

Food-derived antithrombotic peptides: Preparation, identification, and interactions with thrombin.